Latest atopic dermatitis Stories
Welichem Biotech, a development-stage biopharmaceutical company, has announced positive results from its Phase IIa clinical trial of its drug candidate, WBI-1001, a new, non-steroid, topical cream treatment for atopic dermatitis.
Provectus Pharmaceuticals has successfully completed its Phase I clinical trial of PV-10 in the treatment of recurrent breast carcinoma.
Chronic stress can lead to skin irritation and persistent itching that leads to bothersome scratching, a Canadian neuroimmunologist reported in a study. Dr.
LA JOLLA, Calif., Oct 27 /PRNewswire/ -- DermTech, a biotechnology company developing EGIR(TM) (Epidermal Genetic Information Retrieval) technology for the non-invasive early detection of melanoma, drug development and other applications, and Rady Children's Hospital-San Diego, today announced the initiation of a study involving the use of the company's EGIR technology as a vehicle to evaluate oral and/or topical Vitamin D as a treatment for atopic dermatitis (eczema).
Oral Vitamin D may help prevent some skin infections: study LOS ANGELES, Oct.
A study led by researchers at the University of California, San Diego School of Medicine suggests that use of oral Vitamin D supplements bolsters production of a protective chemical normally found in the skin, and may help prevent skin infections that are a common result of atopic dermatitis, the most common form of eczema.
By Davies, Jill Hillman, Elizabeth Two local branch board members report on developing and running a study day on prescribing and the management of childhood eczema With the recently published National Institute for Health and Clinical Excellence (NICE) guidance on the management of atopic eczema in children1 and NMC Standards of proficiency for nurse and midwife prescribe(TM),2 this is an ideal time to update colleagues on prescribing for children with atopic eczema.
Researchers say giving fish to children before the age of nine months could decrease the chances of developing eczema.
Fall has arrived, and for one in five children, that means it is eczema season. Eczema, also known as atopic dermatitis (AD), is a chronic skin condition that causes itching, rash, scaliness, redness, inflammation, weeping and crusting of the skin.
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced that it has been issued U.S. Patent number 7,407,940 by the United States Patent and Trademark Office, which includes the company's lead pre-clinical lipohexapeptide candidates.
- In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
- In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.